NasdaqGS:QUREBiotechs
uniQure (QURE) Stock Rises On Cash Runway Despite Deepening Losses
uniQure stock jumped 5.3% to US$42.19 after its Q2 release, a sharp move for a gene therapy developer that is still posting deep losses. The headlines are not about earnings beats. The story is about whether the cash and pipeline can carry the company across a long and expensive bridge to potential commercial launches.
The quarter showed another heavy quarterly loss with basic earnings per share of US$1.22 in the red and revenue of just US$5.8m. The key focus now is the balance sheet...